Pages that link to "Q36691965"
Jump to navigation
Jump to search
The following pages link to Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma. (Q36691965):
Displaying 9 items.
- A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease (Q38605264) (← links)
- Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study (Q39097273) (← links)
- Relative distribution of Gb3 isoforms/analogs in NOD/SCID/Fabry mice tissues determined by tandem mass spectrometry (Q41471485) (← links)
- European expert consensus statement on therapeutic goals in Fabry disease (Q56863633) (← links)
- Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Q64046067) (← links)
- Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype- phenotype correlations (Q64060583) (← links)
- Tandem Mass Spectrometry Quantitation of Lyso-Gb3 and Six Related Analogs in Plasma for Fabry Disease Patients (Q87796372) (← links)
- A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females (Q94957003) (← links)
- An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease (Q97517227) (← links)